Benidipine - Kyowa Kirin
Alternative Names: Benidipine hydrochloride; Caritec; Coniel; KW 3049; Nacadipine; NakadipineLatest Information Update: 05 Nov 2023
At a glance
- Originator Kyowa Hakko
- Developer Bristol-Myers Squibb; Deva Holding; Kyowa Hakko; Kyowa Kirin; Sirton Pharmaceuticals; Sun Pharmaceutical Industries
- Class Antihypertensives; Benzene derivatives; Dihydropyridines; Ischaemic heart disorder therapies; Nitrobenzenes; Piperidines; Small molecules; Vasodilators
- Mechanism of Action L-type calcium channel antagonists; N-type calcium channel antagonists; T-type calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Angina pectoris; Essential hypertension
Most Recent Events
- 25 Mar 2015 Ranbaxy Laboratories has been acquired by Sun Pharmaceutical Industries
- 20 Oct 2008 Ranbaxy Laboratories has been acquired by Daiichi Sankyo Company
- 01 Oct 2008 Kirin Pharma Company has merged with Kyowa Hakko to form Kyowa Hakko Kirin